Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol (Oral vs IV) in Secondary Hyperparathyroidism on Dialysis
NCT00537979Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2007
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Sep 2007; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00537979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537979.